Skip to content

Anxiety: all studies

Page 229 of 773: studies 2,281 to 2,290 of 7,721, newest first. Back to the anxiety overview

Research

Effectiveness of web-based mindfulness program on college students with social network addiction.

Medicine March 1, 2023 Li Yang, Lv Na, Jia Xiang Rui

Aims: In this study a web-based mindfulness cultivation program was implemented to investigate its effectiveness on the addiction symptoms and negative emotions of college students with social network addiction. Methods: A total of 66 students were recruited and randomly divided into the intervention group or the control group. Participants in the intervention group received a web-based...

The therapeutic potential of psilocybin in depression resistant to psychotropic drugs

European Psychiatry March 1, 2023 J. Ramírez González, I. Fernández Márquez, Serafín González et al.

Introduction The use of hallucinogens has accompanied the human being throughout history. In the 1970s, studies focused on the therapeutic potential of hallucinogens were blocked due to their misuse in the young population. At present, psilocybin is re-emerging as the center of attention due to its possible therapeutic potential in different psychiatric pathologies such as depression, anxiety...

Psychedelics as Psychiatric Medications

March 1, 2023 David Nutt, David Castle 4 citations

Abstract There is substantial contemporary interest in psychedelic agents as medicines for maladies of the mind. This follows research in the 1950s and 1960s exploring the use of LSD and other psychedelics to treat a range of psychiatric illnesses as well as addictions. This research was shut down after prohibition of these drugs; however, the last decade has seen a major renewal of interest in...

Research and Public Interest in Mindfulness in the COVID-19 and Post-COVID-19 Era: A Bibliometric and Google Trends Analysis.

International Journal of Environmental Research and Public Health February 21, 2023 Chan-Young Kwon

Public and research interest in mindfulness has been growing, and the Coronavirus disease 2019 (COVID-19) pandemic seems to have accelerated this growth. This study was conducted to investigate the public and research interest in mindfulness in the context of COVID-19. The term 'Mindfulness' was searched in Google Trends, and data were collected from December 2004 to November 2022. The...

Efficacy of a single-session online ACT-based mindfulness intervention among undergraduates in lockdown during the COVID-19 pandemic.

Trends in Psychiatry and Psychotherapy February 17, 2023 Nicholas Tze Ping Pang, Vincent Chung Sheng Tio, Amardeep Singh Bhupendar Singh et al.

COVID-19 has trickle-down psychological effects on multiple strata of society, particularly university students. Apart from the worry of contracting or spreading COVID-19, Malaysian university students were also locked down on their campuses, suffering significant psychological distress. Hence, an online mindfulness intervention was proposed to alleviate psychological distress and improve...

Effects of Mindfulness and Holotropic Breathwork on the Rehabilitation of Adolescents Who Use Psychoactive Substances: A Pilot Study

Research Square February 14, 2023 Frank Sánchez-Quijano, Diana Ximena Puerta-Cortés, Julio Eduardo Mazorco-Salas preprint

Abstract This pilot study aims to compare the effects of mindfulness and holotropic breathwork treatments on adolescents in the rehabilitation process for psychoactive substance use. Participants comprised 18 female adolescents aged 15–18 admitted to the Fundación Grupo de Apoyo, affiliated with the Colombian Family Welfare Institute. The Fundación is dedicated to rehabilitation from,...

Arketamine for cognitive impairment in psychiatric disorders

European Archives of Psychiatry and Clinical Neuroscience February 14, 2023 Kenji Hashimoto 40 citations

Cognitive impairment has been observed in patients with various psychiatric disorders, including schizophrenia, major depressive disorder (MDD), and bipolar disorder (BD). Although modern therapeutic drugs can improve certain symptoms (i.e., psychosis, depression) in these patients, these drugs have not been found to improve cognitive impairment. The N-methyl-D-aspartate receptor antagonist...

Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report

Frontiers in Psychiatry February 9, 2023 Anya Ragnhildstveit, Miriam Kaiyo, Matthew Brian Snyder et al. 10 citations

Background A dissociative subtype of posttraumatic stress disorder, known as “D-PTSD”, has been included in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. In addition to meeting criteria for PTSD, patients endorse prominent dissociative symptoms, namely depersonalization and derealization, or detachment from one's self and surroundings. At present, this population is...

Exploring Young Adults' Perspectives of Participation in a Mindfulness-Based Music Therapy Intervention Before and During the COVID-19 Pandemic.

Journal of adolescent and young adult oncology February 8, 2023 Carolyn S Phillips, Julianna Bockhoff, Donna L Berry et al.

Purpose: To explore adolescent and young adults' (AYAs) experiences with participation in a mindfulness-based music therapy intervention during cancer treatment before and during the COVID-19 pandemic. Methods: Sixteen young adults (20-39 years old) who received cancer treatment and participated in a mindfulness-based music therapy intervention for anxiety and stress were interviewed using a...

Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents

Biomedicines February 5, 2023 Erika Plazas, Nicoletta Faraone 40 citations

Neuropsychiatric diseases such as depression, anxiety, and post-traumatic stress represent a substantial long-term challenge for the global health systems because of their rising prevalence, uncertain neuropathology, and lack of effective pharmacological treatments. The approved existing studies constitute a piece of strong evidence whereby psychiatric drugs have shown to have unpleasant side...

DOI: 10.3390/biomedicines11020461 (opens in new tab) Anxiety Biosynthesis Clinical trials Ergot alkaloids +11